Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Brink

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
In Vivo (Athens, Greece)|July 8, 2005
High grade cardiac lymphoma vitality monitoring by gadolinium-enhanced magnetic resonance imaging (MRI)T A Bley, R Zeiser, N A Ghanem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapyI Brink, M J Reinhardt, S Hoegerle, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 21, 2001
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesionsA Imdahl, S Jenkner, I Brink, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Effects of methylprednisolone and 21-aminosteroids on mitogen-induced interleukin-6 and tumor necrosis factor-alpha production in human peripheral blood mononuclear cellsF Buttgereit, I Brink, B Thiele, et al.
European Journal of Radiology|June 14, 2005
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of boneN Ghanem, M Uhl, I Brink, et al.
Nuklearmedizin. Nuclear Medicine|February 26, 2003
[Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading]I Brink, E U Nitzsche, M Mix, et al.
Nuklearmedizin. Nuclear Medicine|October 18, 2006
PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. A pilot studyA Lange-Nolde, T Zajic, M Slawik, et al.
Nuklearmedizin. Nuclear Medicine|May 7, 2002
Lymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the resultsI Brink, Th Klenzner, Th Krause, et al.
Anticancer Research|October 15, 2010
Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancerM Klar, P T Meyer, K Hancke, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2004
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinomaI Brink, M Hentschel, T A Bley, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
In Vivo (Athens, Greece)|July 8, 2005
High grade cardiac lymphoma vitality monitoring by gadolinium-enhanced magnetic resonance imaging (MRI)T A Bley, R Zeiser, N A Ghanem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapyI Brink, M J Reinhardt, S Hoegerle, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 21, 2001
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesionsA Imdahl, S Jenkner, I Brink, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Effects of methylprednisolone and 21-aminosteroids on mitogen-induced interleukin-6 and tumor necrosis factor-alpha production in human peripheral blood mononuclear cellsF Buttgereit, I Brink, B Thiele, et al.
European Journal of Radiology|June 14, 2005
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of boneN Ghanem, M Uhl, I Brink, et al.
Nuklearmedizin. Nuclear Medicine|February 26, 2003
[Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading]I Brink, E U Nitzsche, M Mix, et al.
Nuklearmedizin. Nuclear Medicine|October 18, 2006
PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. A pilot studyA Lange-Nolde, T Zajic, M Slawik, et al.
Nuklearmedizin. Nuclear Medicine|May 7, 2002
Lymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the resultsI Brink, Th Klenzner, Th Krause, et al.
Anticancer Research|October 15, 2010
Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancerM Klar, P T Meyer, K Hancke, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2004
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinomaI Brink, M Hentschel, T A Bley, et al.
Pageof 5